Literature DB >> 15509692

Miniature tissue microarrays for HercepTest standardisation and analysis.

C Gulmann1, P Loring, A O'Grady, E Kay.   

Abstract

AIMS: To assess the practicality of using a miniature tissue microarray (TMA) with several examples of each HercepTest score from 0 to 3+ as a control for routine HercepTest immunohistochemistry.
METHODS: A TMA was constructed from in house cases of breast cancer where HercepTest on the whole sections showed scores 0, 1+, 2+, or 3+. The TMA, which measured 5 x 5 mm, was designed with four rows (each representing scores 0, 1+, 2+, and 3+), with five 0.6 mm cores from separate cases. In all, 20 individual cases were represented and the TMA took less than one hour to construct. Fifty sequential 4 microm sections were cut from the TMA to maximise the number of available sections. They were stored at 4 degrees C for 1-270 days and when a case needed HercepTest staining the section was added to the TMA tissue control slide.
RESULTS: All slides contained tissue spots and immunohistochemical staining was consistent throughout the time period.
CONCLUSIONS: The miniature TMA with examples of all HercepTest scores described here is an ideal tissue control and can be used as a visual reference for scoring a case. Slides stored at 4 degrees C could be used for up to 270 days.

Entities:  

Mesh:

Year:  2004        PMID: 15509692      PMCID: PMC1770483          DOI: 10.1136/jcp.2004.018689

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Tissue microarrays: a new approach for quality control in immunohistochemistry.

Authors:  J Packeisen; H Buerger; R Krech; W Boecker
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

2.  Best Practice No 176: Updated recommendations for HER2 testing in the UK.

Authors:  I O Ellis; J Bartlett; M Dowsett; S Humphreys; B Jasani; K Miller; S E Pinder; A Rhodes; R Walker
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

3.  Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.

Authors:  Forrest D Hsu; Torsten O Nielsen; Abdulmohsen Alkushi; Bev Dupuis; David Huntsman; Chih Long Liu; Matt van de Rijn; C Blake Gilks
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

4.  A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer.

Authors:  Anthony Rhodes; Bharat Jasani; Jérĵme Couturier; Mark J McKinley; John M Morgan; Andrew R Dodson; Hossein Navabi; Keith D Miller; André J Balaton
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

5.  The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing.

Authors:  H Battifora
Journal:  Lab Invest       Date:  1986-08       Impact factor: 5.662

6.  Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries.

Authors:  Anthony Rhodes; Bharat Jasani; Elizabeth Anderson; Andrew R Dodson; André J Balaton
Journal:  Am J Clin Pathol       Date:  2002-09       Impact factor: 2.493

7.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

  7 in total
  2 in total

1.  Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis.

Authors:  Jian-Xian Yu; Lin Cui; Qi-Yi Zhang; Hua Chen; Ping Ji; Hong-Jun Wei; Hai-Yan Ma
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  An alternative high output tissue microarray technique.

Authors:  Yuan Shi; Deming He; Yingyong Hou; Qin Hu; Chen Xu; Yalan Liu; Dongxian Jiang; Jieakesu Su; Haiying Zeng; Yunshan Tan
Journal:  Diagn Pathol       Date:  2013-01-21       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.